July 26th, 2017
•Toll-like receptor (TLR) signaling plays an important role in the pathophysiology of many human inflammatory diseases, and regulating TLR responses by bioactive nanoparticles is anticipated to be beneficial in many inflammatory conditions. THP-1 cell-based reporter cells provide a versatile and robust screening platform for identifying novel inhibitors of TLR signaling.
Tags
Vídeos Relacionados
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
High Content Screening in Neurodegenerative Diseases
A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model
Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados